Smoking Behavior Tendency and Your Genetics

Written by Scott Peeples, BS Biomedical Sciences · ExomeDNA Founder Reviewed by ExomeDNA Editorial Process Last reviewed: 2026-05-25

This page provides wellness education and is not a substitute for clinical care.

Smoking behavior tendency is the heritable component of whether a person ever becomes a smoker, studied by comparing people who smoked at any point in their life with those who never did. Large genome-wide analyses have associated multiple chromosomal regions with this tendency — including variants near ARID5B, a transcription regulator expressed in brain tissue — in studies spanning hundreds of thousands of individuals.^[¹][²] Below: the biology of smoking initiation genetics, what population research shows, and how this profile relates to health awareness.

What is smoking behavior tendency?

Smoking behavior tendency reflects the heritable component of whether someone ever starts smoking. It is derived from studies categorizing people as "ever smokers" (anyone who smoked at any point) versus "never smokers," then comparing their genomes to identify regions associated with tobacco initiation.

This trait is distinct from cessation ability (whether someone can quit) and nicotine dependence (how strongly someone becomes dependent once smoking). The question here is the starting point: the genetic factors that, in population studies, associate with whether a person begins tobacco use at all. For the genetics of quitting, see Smoking Cessation Ability.

The "ever vs never" comparison captures genetic factors influencing the reward pathway's initial response to nicotine, behavioral risk-taking tendencies, stress responses that make tobacco use self-reinforcing, and neurological factors that shape how quickly and strongly nicotine initiates dependence.

The genetics behind smoking behavior

Smoking behavior tendency is highly polygenic — hundreds of genetic variants distributed across the genome collectively shape the biological susceptibility to tobacco initiation. No single gene determines whether a person smokes; rather, an accumulating profile of small genetic effects shapes the biological landscape in which tobacco exposure either takes hold or doesn't.

Among the stronger genetic signals in this analysis is a region near ARID5B (AT-rich interaction domain 5B), a transcription factor expressed in brain tissues and immune cells. ARID5B regulates the expression of other genes involved in neural development and stress response — functions that may link it to the behavioral systems underlying risk-taking and addiction initiation (Author et al. 2019).^[²]

Also in the associated gene set is ALDH1B1 (aldehyde dehydrogenase 1B1), an enzyme that metabolizes aldehydes — a category of reactive compounds that includes those produced during tobacco combustion. Genetic variation in ALDH1B1 may influence how the body processes tobacco-derived aldehydes, potentially shaping the subjective experience of early smoking and how aversive or reinforcing that experience is.

ADGRB2 (adhesion G protein-coupled receptor B2) is another gene in the association set. ADGRB2 is expressed specifically in the brain, where it plays a role in angiogenesis regulation and neuronal signaling. Its brain-specific expression places it in the neurological systems that tobacco use research consistently implicates in initiation and dependence.

Multiple independent chromosomal regions associated with smoking initiation have been identified in genome-wide analyses spanning hundreds of thousands of individuals — confirming the highly polygenic architecture of tobacco use behavior and the real but modest contribution of inherited factors to smoking onset.^[¹][²]

Population-level genetic factors influencing smoking initiation appear to act through convergent pathways: the mesolimbic dopamine system (which determines how reinforcing first nicotine exposures are), stress-response circuitry (which shapes tobacco's appeal as a coping mechanism), and neurological factors related to impulsivity and novelty-seeking. Variants across all of these systems contribute small effects that accumulate into an overall genetic tendency (Author et al. 2018).^[¹]

What the research says

Research base: Robust. The genetics of smoking initiation is among the most extensively studied behavioral-genetic questions, with replication across multiple large cohorts, diverse ancestral backgrounds, and independent research groups. The "ever vs never smoker" phenotype has clean epidemiological definition, enabling population-scale comparisons.

Large-scale genome-wide analyses — including studies involving hundreds of thousands of participants — have identified robust genetic associations with smoking initiation in loci distributed across the genome (Author et al. 2018; Author et al. 2019).^[¹][²] Polygenic scores constructed from these associations predict statistically meaningful differences in smoking rates across population quintiles, though with substantial individual variation within each quintile.

Heritability estimates for smoking initiation range from approximately 40 to 60 percent in twin and family studies — placing it firmly among moderately heritable behavioral traits, alongside personality dimensions and other substance use phenotypes. Environmental factors — access to tobacco, social environment, early exposures, marketing — account for the remaining variation (Author et al. 2020).^[³]

For the statistical methods behind variant selection and polygenic scoring — see our methodology page for the full approach.

How smoking behavior tendency affects you

A higher genetic tendency score reflects population-level patterns showing that people with similar genetic profiles smoked at higher rates. This is a statistical observation about population distributions, not an individual prediction or determination.

Important distinctions:

• This score does not predict whether any individual person will or won't smoke
• Environmental factors — access to tobacco, social environment, early exposures — are at least as important as genetics in actual smoking behavior
• Many people with high genetic tendency scores never smoke; many with lower scores do
• The score describes tendencies that interacted with actual life circumstances to produce actual smoking history

For people who have never smoked, this profile is primarily informational. The biological tendencies it reflects are real, but they are not deterministic — genetics provides a tendency; environment and behavior shape the outcome.

For people who currently smoke or have smoked, this profile may offer useful context: the biological pull toward nicotine is partly inherited, which matters for how cessation difficulty is framed and approached. See Smoking Cessation Ability for the genetics of quitting.

Working with your smoking behavior profile

What research suggests based on smoking initiation genetics:

1. Environmental context shapes genetic expression. The genetic tendencies measured here do not operate in a vacuum. Tobacco-free environments, awareness of biological tendencies, and early preventive information all modify whether genetic tendencies translate to smoking behavior. Social and structural factors are the most powerful modifiers.
2. For current smokers: A higher genetic tendency reflects that the biological reinforcement from nicotine may be stronger than average — relevant context for cessation planning. This points toward more intensive pharmacological support and behavioral tools. See Smoking Cessation Ability.
3. For people who quit: A higher genetic tendency and successful quit represents overcoming real biological pull. Relapse prevention strategies — reducing cue exposure, maintaining social support, managing stress — remain relevant long-term precisely because the underlying tendency persists.
4. Understanding shared biology. Genetic factors associated with smoking initiation overlap with reward sensitivity, stress reactivity, and some personality dimensions. Framing this as a neurobiological profile rather than a character trait shifts the approach from blame toward practical tools.
5. Aldehyde metabolism variation. Variants in ALDH1B1 in the associated gene set may influence how tobacco-derived aldehydes are processed — potentially affecting the subjective experience of early smoking. This biological factor is separate from nicotine reinforcement itself.
6. Brain-expressed gene set. Multiple genes in this association set — including ADGRB2 and ARID5B — are expressed in neurological tissues, consistent with the understanding that smoking initiation reflects neurobiological tendencies as much as behavioral choice.

Environmental and structural factors interact substantially with genetic smoking tendency — studies show that genetic predisposition to smoking initiation is more likely to manifest in social environments where tobacco is normalized and available, and less likely where tobacco exposure is limited or culturally absent.^[³]

Related traits and genes

Smoking behavior tendency genetics overlaps with several related profiles:

• Smoking Cessation Ability: the genetic component of successfully quitting; partially distinct from initiation genetics but shares reward pathway biology
• Nicotine Dependence Severity: how strongly nicotine creates physical and behavioral dependence once smoking begins — the biological step between initiation and established addiction
• Alcohol Use Behavior: shares mesolimbic reward pathway genetics; genetic correlations between tobacco and alcohol use are well-established in large GWAS
• Dopamine Response Tendency: dopaminergic reward sensitivity variants appear across multiple substance use traits including smoking initiation
• Risk-Taking Tendency: behavioral risk-taking genetics overlaps with smoking initiation in some studies, consistent with shared impulsivity and novelty-seeking pathways

The ARID5B gene associated with smoking behavior tendency also appears in immune and metabolic traits in the ExomeDNA profile — its functions span multiple biological systems beyond addiction.

Frequently asked questions

Does a high genetic smoking tendency mean someone will become a smoker? No. Genetic tendency describes population-level statistical patterns, not individual outcomes. Many people with high tendency scores never smoke; environmental context, life circumstances, and personal choices determine actual behavior. Genetics shapes the biological pull — it doesn't write the story.

Why do some people get hooked on cigarettes immediately while others don't? Multiple biological factors shape this: how reinforcing the first nicotine exposures are (influenced by dopamine pathway genetics), how quickly nicotine receptors adjust in the brain, and how aversive or pleasant early smoking experiences are (influenced by aldehyde metabolism variation). Individual variation in all of these contributes to who develops dependence quickly versus who doesn't.

Are some ancestral groups more genetically prone to smoking initiation? Population-level differences in smoking rates reflect a mix of genetic, cultural, economic, and marketing factors. Genetic studies have found some variation in smoking-related signals across ancestral groups, but these genetic differences explain only a small fraction of actual smoking rate variation across populations. Structural and social factors are much larger drivers of population-level differences.

Does the genetic smoking tendency score directly affect cancer or cardiovascular outcomes? No — this score measures genetic tendency toward tobacco initiation, not direct cancer or cardiovascular genetics. Tobacco use, if it occurs, increases cancer and cardiovascular outcomes through separate pathways. The tendency score itself does not carry those outcomes.

What is the difference between smoking behavior tendency and nicotine dependence? Smoking behavior tendency reflects the genetic factors associated with ever starting to smoke. Nicotine dependence severity reflects how strongly the brain becomes dependent once smoking is established. The two are related but distinct — someone can initiate smoking without becoming strongly dependent, and the genetics of each phenotype are partially different.

Wellness Information. ExomeDNA provides educational interpretation of genetic variants for general wellness purposes only. Results are not a clinical test, not a treatment recommendation, and not a substitute for professional healthcare. Consult a licensed clinician before making health decisions. See our methodology and test limitations for details.

References

1. [Smoking behavior GWAS study (2018). PMID: 30271922.]
2. [Large-scale smoking initiation genetic analysis (2019). PMID: 30643258.]
3. [Polygenic smoking behavior population study (2020). PMID: 32231276.]

Data sources:

• GWAS Catalog (NHGRI-EBI, accessed 2026-05-20)
• Open Targets Platform (CC0 1.0, accessed 2026-05-20)
• ClinVar (NCBI, accessed 2026-05-20) — entries at ≥2-star review status
• ClinGen Gene-Disease Validity (CC0 1.0, accessed 2026-05-20)

This page is published by the ExomeDNA Research Team. Last reviewed: 2026-05-25.